231-240 of 318 results
An overhaul of regulation of software as a medical device - what's on the horizon?
Proposed new regulatory rules for software as a medical device will if enacted have serious implications for suppliers to the Australian market who will likely have to meet more stringent requirements that could conflict with those in the US and Europe Special Counsel Ric Morgan and Senior Associate ...
ICANN caught in regulatory web
Since it took effect in May 2018 across the entire European Union, the General Data Protection Regulation has sent shockwaves through countless internet infrastructure industries ...
Second round of changes to Australia's IP laws released for comment
IP Australia has released draft legislation to implement the second part of the Government's response to the Productivity Commission's inquiry into IP arrangements. Senior Associate Lauren John reports. ...
US Postal Service breaches copyright in the Statue of Las Vegas
In this issue we look at challenges for domain name searching posed by the GDPR the second round of draft amendments to the Patents Act developments in the patentability of computer-implemented inventions the dangers of falsely marking products as patented the latest brand wars in the Federal Court ...
Patent examination guidelines in the wake of Myriad
Following public consultation on proposed examination guidelines issued on 16 October 2015 the Commissioner of Patents has established a revised examination practice taking into account the High Courts decision in emDArcy v Myriad Genetics Incem Dr Trevor Davies Partner at Allens Patent amp Trade ...
Changes to New Zealand patent law - the deadline approaches
Changes to New Zealand's patent legislation which come into effect on 13 September 2014 will align it more closely to Australia's patent law ...
Review your IP arrangements: IP exemption from competition laws soon to be repealed
Section 51(3) of the Competition and Consumer Act 2010 (CCA), which currently exempts conditional licensing or assignment of IP rights from most of the prohibitions on anti-competitive conduct in the CCA, will be repealed. ...
What do the Swiss and artificial sweetener have to do with patents?
The recent Federal Court decision in Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2019] FCA 28 deals with fascinating issues for patentees seeking to enforce Swiss-style claims against makers of bioequivalent products. ...
Faster TGA disclosure - what it means for pharmaceutical patent litigation
The TGA has consulted on whether it should disclose earlier that a prescription medicine is under evaluation and what types of prescription medicines should be published. ...
Major new proposals for regulating personalised medical devices
Proposed amendments to the regulation of personalised medical devices, which introduce a set of new internationally haromised definitions will have a significant impact on the industry ...